In addition to effectively lowering glucose, incretin drugs, which include glucagon-like peptide 1 receptor (GLP1R) agonists and dipeptidyl peptidase 4 (DPP4) inhibitors, can also reduce blood pressure, body weight, the risk of developing or worsening chronic kidney disease and/or atherosclerotic cardiovascular events, and the risk of death
It assists the organisation to be able to use more fat as a source of power, which conserves glycogen and allows the body to sustain more workouts
Also, the length of PPI use is an important aspect to consider, and to lessen the risk of side effects, should be kept as short as possible to achieve the desired result
Neurological Tinnitus: Caused by a neurological disorder, such as Meniere's disease or head trauma, this form of tinnitus results from a malfunction in the brain's processing of sound